Error: Could not add to watchlist. X

ArQule Inc

+ Watchlist
ARQL:US
NASDAQ GM
1.64
USD
0.06
3.53%
As of 15:20:41 ET on 07/30/2015.
Open
1.70
Day Range
1.60 - 1.75
Volume
280,845
Previous Close
1.70
52Wk Range
1.04 - 2.50
1 Yr Return
20.44%
Open
1.70
Day Range
1.60 - 1.75
Volume
280,845
Previous Close
1.70
52Wk Range
1.04 - 2.50
1 Yr Return
20.44%
YTD Return
35.25%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.33
Market Cap (m USD)
108.049
Shares Outstanding (m)
62.819
Price/Sales (TTM)
9.10
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ArQule Inc. develops cancer therapeutics based on its proprietary Activated Checkpoint Therapy platform. The Company's platform is designed to produce small molecule compounds that selectively kill cancer cells while leaving normal cells unharmed. ArQule's products are intended to be effective against multiple types of cancer.
ADDRESS
19 Presidential Way
Woburn, MA 01801-5140
United States
PHONE
1-781-994-0300
  • Paolo Pucci
    Chief Executive Officer
  • Peter S Lawrence
    President/COO/Secy/Gen Cnsl
  • Robert J Weiskopf
    CFO/Treasurer
  • Brian Schwartz
    Senior VP/Chief Medical Ofcr
  • William B Boni
    VP:Investor Relations
Show More